Advertisement

ADVERTISEMENT

carotid artery stenting

Case Report
Transradial Carotid Artery Stenting Complicated With Neck Hematoma: Conservative Is a Valid Option!
02/16/2021

Osama Shoeib, MD, PhD1; Hazem Warda, MD, PhD2

 

1Alhyatt Heart and Vascular Center, Alexandria, Egypt; 2Tanta University, Cardiology Department, Tanta, Egypt

Osama Shoeib, MD, PhD1; Hazem Warda, ...
Carotid artery stenting—when performed by an experienced operator using an embolic protection device—provides a good alternative for carotid endarterectomy in high-risk patients.
Carotid artery stenting—when performed by an experienced operator using an embolic protection device—provides a good alternative for carotid endarterectomy in high-risk patients.
Carotid artery stenting—when...
02/16/2021
Vascular Disease Management
Taking a Look at the Coming “Radial Revolution”
Editor's Corner
Taking a Look at the Coming “Radial Revolution”
02/16/2021

Craig Walker, MD, FACC, FACP

 

Cardiovascular Institute of the South, Houma, Louisiana

Craig Walker, MD, FACC, FACP   Card...
Dr. Walker comments on Dr. Osama Shoeib and colleagues’ article “Transradial Carotid Artery Stenting Complicated With Neck Hematoma: Conservative is a Valid Option!”
Dr. Walker comments on Dr. Osama Shoeib and colleagues’ article “Transradial Carotid Artery Stenting Complicated With Neck Hematoma: Conservative is a Valid Option!”
Dr. Walker comments on Dr. Osama...
02/16/2021
Vascular Disease Management
New Techniques
Micromesh Dual-Layer Technology for Carotid Artery Stents
10/02/2016

Silke Hopf-Jensen, MD; Maximilian Leissner,MD; Leonardo Marques, MD; Michael Preiss, MD; Stefan Müller-Hülsbeck, MD, PhD

Institute for Diagnostic and Interventional Radiology and Neuroradiology, Diakonissenhospital, Flensburg, Germany

Silke Hopf-Jensen, MD; Maximilian Lei...
The authors evaluate the performance and effectiveness of micromesh dual-layer technology as a new option for stent-protected angioplasty and to present it as part of the portfolio of carotid artery stents.
The authors evaluate the performance and effectiveness of micromesh dual-layer technology as a new option for stent-protected angioplasty and to present it as part of the portfolio of carotid artery stents.
The authors evaluate the...
10/02/2016
Vascular Disease Management
Case Series
Persistent Hypotension After Carotid Artery Stenting
02/06/2012

Dr. Samira Arami
Guilan University of Medical Science, Dr. Heshmat Heart Hospital, Rasht, Iran

Dr. Samira Arami Guilan University of...
Abstract carotid artery stenting is the treatment of choice in high-risk patients with extracranial carotid occlusive disease. Bradycardia and hypotension are well-recognized complications of this procedure and are often transient and...
Abstract carotid artery stenting is the treatment of choice in high-risk patients with extracranial carotid occlusive disease. Bradycardia and hypotension are well-recognized complications of this procedure and are often transient and...
Abstract carotid artery stenting...
02/06/2012
Vascular Disease Management
Review
When and How to Use Proximal Occlusion Devices During Carotid Artery Angioplasty and Stenting
01/06/2012

L. Nelson Hopkins, MD, et al

L. Nelson Hopkins, MD, et al
Methods of cerebral embolic protection during carotid artery stenting focusing on the newest method, proximal occlusion, are discussed in this manuscript.
Methods of cerebral embolic protection during carotid artery stenting focusing on the newest method, proximal occlusion, are discussed in this manuscript.
Methods of cerebral embolic...
01/06/2012
Vascular Disease Management
Case Report
Low Risk of Intracerebral Hemorrhage with Adjunctive IIb/IIIa Inhibitors in Ad Hoc Carotid Artery Stenting
12/02/2011

Hugh B. Milteer, Jr, BA, MBA

Hugh B. Milteer, Jr, BA, MBA
We assessed the risk of intracerebral hemorrhage in patients who underwent carotid artery stenting (CAS) and received glycoprotein IIb/IIIa inhibition as adjunctive antiplatelet therapy.
We assessed the risk of intracerebral hemorrhage in patients who underwent carotid artery stenting (CAS) and received glycoprotein IIb/IIIa inhibition as adjunctive antiplatelet therapy.
We assessed the risk of...
12/02/2011
Vascular Disease Management
Original Research
Lessons Learned from the Case Series of Carotid Artery Stenting in a Community Hospital
07/06/2011

Mateen F. Abidi, MD

Mateen F. Abidi, MD
Carotid artery stenting (CAS) is evolving as a less invasive alternative to carotid endarterectomy (CEA) to treat patients with carotid artery stenosis at high surgical risk. However, little is known about the quality and safety of CAS in a...
Carotid artery stenting (CAS) is evolving as a less invasive alternative to carotid endarterectomy (CEA) to treat patients with carotid artery stenosis at high surgical risk. However, little is known about the quality and safety of CAS in a...
Carotid artery stenting (CAS) is...
07/06/2011
Vascular Disease Management
Interview
CREST: Further Data Analysis Confirms Wisdom of Appropriate Patient Stratification
05/27/2010

Christopher J. White, MD

Christopher J. White, MD
There is now more “texture” to the data, but the conclusion is still that there are no significant differences between the outcomes with carotid artery stenting (CAS) and carotid endarterectomy (CEA). In essence, there were more minor strokes...
There is now more “texture” to the data, but the conclusion is still that there are no significant differences between the outcomes with carotid artery stenting (CAS) and carotid endarterectomy (CEA). In essence, there were more minor strokes...
There is now more “texture” to...
05/27/2010
Vascular Disease Management
Interview
The Mo.Ma® Ultra Proximal Cerebral Protection Device: An Effective New Tool
02/02/2010

Interview with Co-Principal Investigators of the ARMOUR Trial: Gary Ansel, MD and L. Nelson Hopkins, MD
 

Interview with Co-Principal Investiga...
Interview with Co-Principal Investigators of the ARMOUR Trial: Gary Ansel, MD and L. Nelson Hopkins, MD
Interview with Co-Principal Investigators of the ARMOUR Trial: Gary Ansel, MD and L. Nelson Hopkins, MD
Interview with Co-Principal...
02/02/2010
Vascular Disease Management
Review
Impact of Technique and Device Selection on Clinical Outcomes in Carotid Artery Stenting
01/07/2010

Daniel J. McCormick, DO

Daniel J. McCormick, DO
Each year about 780,000 people experience a new or recurrent stroke, accounting for 17% of cardiovascular deaths. Approximately 80% of strokes are caused by focal cerebral ischemia and the remaining 20% are caused by hemorrhage.
Each year about 780,000 people experience a new or recurrent stroke, accounting for 17% of cardiovascular deaths. Approximately 80% of strokes are caused by focal cerebral ischemia and the remaining 20% are caused by hemorrhage.
Each year about 780,000 people...
01/07/2010
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use